Smith & Nephew shares jumped Monday after the news was released that the company had rejected an acquisition by Johnson & Johnson, according to a WallStreet.com report.
Smith & Nephew management says that the company is undervalued, as the ADRs are were up almost 11 percent on Monday. Other leading device companies, such as Stryker and Medtronic, could attempt to acquire Smith & Nephew in the future. Zimmer Holdings has also been mentioned as a possible company seeking the acquisition, but the agreement would be more like a merger since the two companies have more equal offerings.
Read the WallStreet.com report on Smith & Nephew.
Read other coverage on Smith & Nephew:
- Smith & Nephew Responds to FDA Letter of Warning
- Smith & Nephew Adds 100 Employees
- Smith & Nephew CEO Speaks About Orthopedic Device Environment
Smith & Nephew management says that the company is undervalued, as the ADRs are were up almost 11 percent on Monday. Other leading device companies, such as Stryker and Medtronic, could attempt to acquire Smith & Nephew in the future. Zimmer Holdings has also been mentioned as a possible company seeking the acquisition, but the agreement would be more like a merger since the two companies have more equal offerings.
Read the WallStreet.com report on Smith & Nephew.
Read other coverage on Smith & Nephew:
- Smith & Nephew Responds to FDA Letter of Warning
- Smith & Nephew Adds 100 Employees
- Smith & Nephew CEO Speaks About Orthopedic Device Environment